Wilbanks Smith & Thomas Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,641
| Closed | -$407K | – | 496 |
|
|
2023
Q2 | $407K | Sell |
23,641
-1,496
| -6% | -$25.7K | 0.01% | 358 |
|
|
2023
Q1 | $417K | Hold |
25,137
| – | – | 0.01% | 340 |
|
|
2022
Q4 | $192K | Hold |
25,137
| – | – | 0.01% | 480 |
|
|
2022
Q3 | $250K | Buy |
25,137
+41
| +0.2% | +$408 | 0.01% | 402 |
|
|
2022
Q2 | $228K | Hold |
25,096
| – | – | 0.01% | 431 |
|
|
2022
Q1 | $209K | Buy |
+25,096
| New | +$209K | 0.01% | 472 |
|
|
2021
Q4 | – | Sell |
-5,702
| Closed | -$267K | – | 510 |
|
|
2021
Q3 | $267K | Buy |
+5,702
| New | +$267K | 0.01% | 420 |
|